Year |
Citation |
Score |
2019 |
Arrigoni P, Ruprecht JC, Chasse DAD, Glass KA, Andress B, Guilak F, Weinberg JB, McNulty AL. Optimization of Meniscus Cell Transduction Using Lentivirus and Adeno-Associated Virus for Gene Editing and Tissue Engineering Applications. Cartilage. 1947603519880321. PMID 31609141 DOI: 10.1177/1947603519880321 |
0.518 |
|
2019 |
Ruprecht JC, Waanders TD, Rowland CR, Nishimuta JF, Glass KA, Stencel J, DeFrate LE, Guilak F, Weinberg JB, McNulty AL. Meniscus-Derived Matrix Scaffolds Promote the Integrative Repair of Meniscal Defects. Scientific Reports. 9: 8719. PMID 31213610 DOI: 10.1038/S41598-019-44855-3 |
0.727 |
|
2018 |
Rowland CR, Glass KA, Ettyreddy AR, Gloss CC, Matthews JRL, Huynh NPT, Guilak F. Regulation of decellularized tissue remodeling via scaffold-mediated lentiviral delivery in anatomically-shaped osteochondral constructs. Biomaterials. 177: 161-175. PMID 29894913 DOI: 10.1016/J.Biomaterials.2018.04.049 |
0.788 |
|
2016 |
Moutos FT, Glass KA, Compton SA, Ross AK, Gersbach CA, Guilak F, Estes BT. Anatomically shaped tissue-engineered cartilage with tunable and inducible anticytokine delivery for biological joint resurfacing. Proceedings of the National Academy of Sciences of the United States of America. PMID 27432980 DOI: 10.1073/Pnas.1601639113 |
0.769 |
|
2016 |
Glass KA, Rowland CR, Ettyreddy AR, Brunger JM, Huynh NP, Gersbach CA, Guilak F. 502. Biomaterial-Mediated Lentiviral Delivery of Anti-Inflammatory Genes in Cartilage-Derived Matrix Hemispheres Molecular Therapy. 24: S199-S200. DOI: 10.1016/S1525-0016(16)33311-1 |
0.728 |
|
2014 |
Glass KA, Link JM, Brunger JM, Moutos FT, Gersbach CA, Guilak F. Tissue-engineered cartilage with inducible and tunable immunomodulatory properties. Biomaterials. 35: 5921-31. PMID 24767790 DOI: 10.1016/J.Biomaterials.2014.03.073 |
0.763 |
|
2013 |
Perez-Pinera P, Kocak DD, Vockley CM, Adler AF, Kabadi AM, Polstein LR, Thakore PI, Glass KA, Ousterout DG, Leong KW, Guilak F, Crawford GE, Reddy TE, Gersbach CA. RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nature Methods. 10: 973-6. PMID 23892895 DOI: 10.1038/Nmeth.2600 |
0.419 |
|
2013 |
Perez-Pinera P, Ousterout DG, Brunger JM, Farin AM, Glass KA, Guilak F, Crawford GE, Hartemink AJ, Gersbach CA. Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nature Methods. 10: 239-42. PMID 23377379 DOI: 10.1038/Nmeth.2361 |
0.667 |
|
2013 |
Glass K, Brunger J, Gersbach C, Guilak F. Tunable expression of IL-1Ra in genetically modified mesenchymal stem cells for cartilage tissue engineering Osteoarthritis and Cartilage. 21: S282-S283. DOI: 10.1016/J.Joca.2013.02.591 |
0.793 |
|
Show low-probability matches. |